Deep Track Capital’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Deep Track Capital’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,041,670	Closed	-$33.6M	–	80
2023 Q4	$33.6M	Hold	2,041,670	–	–	1.12%	36
2023 Q3	$15.8M	Hold	2,041,670	–	–	0.61%	43
2023 Q2	$10.6M	Buy	2,041,670 +875,000	+75%	+$4.46M	0.49%	40
2023 Q1	$6.27M	Buy	+1,166,670	New	+$6.34M	0.26%	49

Deep Track Capital's ORTX Position: Q1 2024 in Review

Deep Track Capital sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 2,041,670 shares — an estimated $33.6M sold.

Deep Track Capital first reported a position in ORTX in Q1 2023 and held it in 4 quarters. The position peaked at $33.6M in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

Deep Track Capital reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Deep Track Capital sold 2,041,670 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $33.6M.
Deep Track Capital first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2023 and held it in 4 quarters.
Deep Track Capital's Orchard Therapeutics plc American Depositary Shares position peaked at $33.6M in Q4 2023.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Deep Track Capital's 13F filing for Q1 2024, filed 15 May 2024.